Titan Pharmaceuticals Inc (TTNP)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current TTNP market cap is 3.68M. The company's latest EPS is USD -6.0914 and P/E is -0.66.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3k | 0 | 0 | 0 | 0 |
| Operating Income | -2.06M | -1.93M | -1.06M | -2.07M | -754k |
| Net Income | -338k | -1.97M | -1.06M | -2.09M | -763k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.61M | 4.84M | 1.53M | 557k | 184k |
| Operating Income | -16.84M | -7.35M | -9.35M | -10.24M | -7.28M |
| Net Income | -16.46M | -18.24M | -8.78M | -10.21M | -5.57M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 10M | 8.09M | 6.65M | 4.35M | 3.6M |
| Total Liabilities | 1.87M | 1.44M | 559k | 356k | 371k |
| Total Equity | 8.13M | 6.64M | 6.09M | 3.99M | 3.23M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 9.52M | 8.09M | 7.99M | 4.06M | 8.09M |
| Total Liabilities | 8.09M | 4.56M | 2.86M | 2.7M | 1.44M |
| Total Equity | 1.43M | 3.53M | 5.14M | 1.36M | 6.64M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.85M | -7.09M | -613k | -2.68M | -3.37M |
| Investing | 228k | 732k | N/A | N/A | N/A |
| Financing | 9.59M | 10M | N/A | N/A | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -15.45M | -17.2M | -7.9M | -8.18M | -7.09M |
| Investing | -256k | -540k | -23k | N/A | 732k |
| Financing | 11.77M | 17.93M | 8.84M | 4.98M | 10M |
| Market Cap | 3.68M |
| Price to Earnings Ratio | -0.66 |
| Price to Sales Ratio | 19.97 |
| Price to Cash Ratio | 0.54 |
| Price to Book Ratio | 0.55 |
| Dividend Yield | - |
| Shares Outstanding | 914.23k |
| Average Volume (1 week) | 122.2k |
| Average Volume (1 Month) | 53.15k |
| 52 Week Change | -47.11% |
| 52 Week High | 14.80 |
| 52 Week Low | 3.03 |
| Spread (Intraday) | 2.14 (38.91%) |
| Company Name | Titan Pharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.titanpharm.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
